HOME >> MEDICINE >> NEWS
H5N1 avian flu virus vaccine induces immune responses in healthy adults

Results from a clinical trial demonstrate that high doses of an experimental H5N1 avian influenza vaccine can induce immune responses in healthy adults. Approximately half of those volunteers who received an initial and a booster dose of the highest dosage of the vaccine tested in the trial developed levels of infection-fighting antibodies that current tests predict would neutralize the virus. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, funded the study, published in the current issue of The New England Journal of Medicine. Preliminary results from this trial were first disclosed late last summer.

"These findings represent an important step forward in the nation's efforts to prepare for the possible emergence of a human pandemic of H5N1 avian influenza," notes NIH Director Elias A. Zerhouni, M.D.

"We are working hard to address the many challenges that remain with regard to the development of an H5N1 vaccine," adds NIAID Director Anthony S. Fauci, M.D. "For example, potentially protective immune responses were seen most frequently at the highest dose of this vaccine. We are investigating other options that may allow us to reduce the dosage--for example, adding an immune booster, or adjuvant, to the vaccine--so we can achieve a more practical immunization strategy." In addition, the U.S. Department of Health and Human Services is pursuing other approaches to an H5N1 vaccine, including vaccines made in cell cultures rather than grown in eggs.

H5N1 avian influenza viruses are of enormous concern to public health officials worldwide. The potential for a human avian flu pandemic looms large, say experts, as daily reports indicate an increasing spread of infection in bird populations in Southeast Asia, Europe, the Middle East and Africa. According to the World Health Organization, as of March 24, 2006, 186 people had been infected with avian flu viruses, and more than half of them
'"/>

Contact: NIAID News Office
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
29-Mar-2006


Page: 1 2 3

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. Veterinarians at increased risk of avian influenza virus infection
3. Human antibodies protect mice from avian flu
4. Syphilis screening, lithium fights neurodegeneration, monoclonal antibodies against avian flu
5. NIAID DNA vaccine for H5N1 avian influenza enters human trial
6. Burmese junta responding too slowly on HIV, TB, malaria and avian flu
7. H9N2 avian flu vaccine paired with adjuvant provokes strong human immune response at low doses
8. Live H5N1 avian flu virus vaccines show protection in animal studies
9. Tunnell Consulting awarded contract to fight avian flu
10. UK grid helps fight avian flu
11. Medical experts: US unlikely to have enough vaccines to stop avian flu

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: avian flu virus vaccine induces immune responses healthy adults

(Date:5/23/2013)... Looking for tips on how to avoid ... of caring for your aging parent? Today the ... released the results of a survey of 335 geriatric care ... , Here are the top 5 tips identified by these ... survey respondents selecting each option): , 1.    Give each family member ...
(Date:5/23/2013)... 23 May 2013.- CNIC researchers have discovered that the ... release of hematopoietic stem cells from the bone marrow ... in the journal Cell ., Neutrophils are leukocytes ... from bacteria and other disease organisms. To perform their ... into contact with microorganisms. However, release of these substances ...
(Date:5/23/2013)... 2013 A medical Internet marketing consulting ... Targeting members of the medical and healthcare community to ... patients, the consulting service is focused on SEO and ... medical Internet marketing agency is providing the service to ... As part of the consulting, the company will draw ...
(Date:5/23/2013)... HOLLOW, NY (PRWEB) May 23, 2013 ... the staff of Phelps Memorial Hospital Center as Medical ... She will direct comprehensive inpatient and outpatient rehabilitation care ... , Dr. Liu received her undergraduate degree in biochemistry ... for four years. She earned her medical degree ...
(Date:5/23/2013)... -- Mild to moderate iodine deficiency during pregnancy may ... British researchers report. Low levels of the so-called ... put her child at risk of poorer verbal and ... found. Pregnant women can boost their iodine levels by ... The finding, published online May 22 in ...
Breaking Medicine News(10 mins):Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Low Prenatal Iodine May Affect Child's Brain Development 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: